BAVRIZTO
LIVE

Serial Number

99548425

Owner

Glaxo Group Limited

Attorney

Christopher M. Hanes

Filing Date

Dec 15, 2025

Add to watchlist:

No watchlists yet
View on USPTO

BAVRIZTO Trademark

Serial Number: 99548425

BAVRIZTO is a trademark filed by Glaxo Group Limited on December 15, 2025. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Glaxo Group Limited (140 trademarks)

GSK Medicines Research Centre
Stevenage SG12NY , GB

Entity Type: 77

Trademark Details

Filing Date

December 15, 2025

Registration Date

Not Registered

Goods & Services

Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; Pharmaceutical preparations for the prevention of infectious diseases; Vaccines; Anti-infectives

Filing History

APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 28, 2026 CNSA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Jul 23, 2026 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 23, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 23, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 23, 2026 REAP
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 23, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 23, 2026 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jul 23, 2026 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Apr 16, 2026 GNS3
LETTER OF SUSPENSION E-MAILED
Apr 16, 2026 GNSL
SUSPENSION LETTER WRITTEN
Apr 16, 2026 CNSL
ASSIGNED TO EXAMINER
Apr 16, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 15, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 15, 2025 NWOS
NEW APPLICATION ENTERED
Dec 15, 2025 NWAP